754 related articles for article (PubMed ID: 28377543)
1. Mycobacterium tuberculosis in solid organ transplantation: incidence before and after expanded isoniazid prophylaxis.
Al-Mukhaini SM; Al-Eid H; Alduraibi F; Hakami HI; Talhi HA; Shoukri M; Ahmed AM; Ahmed Y; Alrajhi AA
Ann Saudi Med; 2017; 37(2):138-143. PubMed ID: 28377543
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in renal transplant recipients: the evidence for prophylaxis.
Currie AC; Knight SR; Morris PJ
Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975
[TBL] [Abstract][Full Text] [Related]
3. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period.
Sidhu A; Verma G; Humar A; Kumar D
Transplantation; 2014 Sep; 98(6):671-5. PubMed ID: 24825525
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.
Gras J; De Castro N; Montlahuc C; Champion L; Scemla A; Matignon M; Lachâtre M; Raskine L; Grall N; Peraldi MN; Molina JM
Transpl Infect Dis; 2018 Oct; 20(5):e12943. PubMed ID: 29890021
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis.
Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K
Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China.
Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM
Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis.
Adamu B; Abdu A; Abba AA; Borodo MM; Tleyjeh IM
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD008597. PubMed ID: 24590589
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management.
Singh N; Paterson DL
Clin Infect Dis; 1998 Nov; 27(5):1266-77. PubMed ID: 9827281
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis following solid organ transplantation.
Lopez de Castilla D; Schluger NW
Transpl Infect Dis; 2010 Apr; 12(2):106-12. PubMed ID: 20002613
[TBL] [Abstract][Full Text] [Related]
11. Management and outcome of latent tuberculosis in living renal transplant donors.
Habhab WT; Alraddadi BM; Idris N; Alghamdi S; Zabani N; Fahmy A; Malik AA; Alwaassia M
Saudi J Kidney Dis Transpl; 2019; 30(1):151-152. PubMed ID: 30804276
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country.
Dodani SK; Nasim A; Aziz T; Naqvi A
Transpl Infect Dis; 2021 Oct; 23(5):e13709. PubMed ID: 34331355
[TBL] [Abstract][Full Text] [Related]
13. Anti-tuberculosis prophylaxis following renal transplantation: acceptable variations?
Field M; Clarke A; Kelleher M; Hamsho A; Mellor S; Ready A; Inston N; van Dellen D
Transpl Infect Dis; 2012 Oct; 14(5):551-4. PubMed ID: 22321406
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcome of tuberculosis in solid organ transplant recipients.
Hsu MS; Wang JL; Ko WJ; Lee PH; Chou NK; Wang SS; Chu SH; Chang SC
Am J Med Sci; 2007 Aug; 334(2):106-10. PubMed ID: 17700199
[TBL] [Abstract][Full Text] [Related]
15. Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients.
Epstein DJ; Subramanian AK
Infect Dis Clin North Am; 2018 Sep; 32(3):703-718. PubMed ID: 30146031
[TBL] [Abstract][Full Text] [Related]
16. Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial.
Kim SH; Lee SO; Park IA; Kim SM; Park SJ; Yun SC; Jung JH; Shin S; Kim YH; Choi SH; Kim YS; Woo JH; Park SK; Park JS; Han DJ
J Antimicrob Chemother; 2015 May; 70(5):1567-72. PubMed ID: 25608587
[TBL] [Abstract][Full Text] [Related]
17. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial.
Torre-Cisneros J; San-Juan R; Rosso-Fernández CM; Silva JT; Muñoz-Sanz A; Muñoz P; Miguez E; Martín-Dávila P; López-Ruz MA; Vidal E; Cordero E; Montejo M; Blanes M; Fariñas MC; Herrero JI; Rodrigo J; Aguado JM
Clin Infect Dis; 2015 Jun; 60(11):1642-9. PubMed ID: 25722196
[TBL] [Abstract][Full Text] [Related]
19. Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients.
Ahmed P; Anwar M; Khan B; Altaf C; Ullah K; Raza S; Hussain I
J Pak Med Assoc; 2005 Sep; 55(9):378-81. PubMed ID: 16302471
[TBL] [Abstract][Full Text] [Related]
20. Empiric vs screening-based use of isoniazid for tuberculosis prophylaxis: Safety and effectiveness in lung transplant recipients in Saudi Arabia.
Korayem GB; Alissa DA; AlSuhaibani NI; AlSwailem GS; AlShammari MA; Yaqoob I; Aljasser DS; Almaghrabi RS
Transpl Infect Dis; 2021 Apr; 23(2):e13473. PubMed ID: 32978858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
